Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer

Immunotherapy in hepatocellular carcinoma: Primed to make a difference?

Immunotherapy for hepatocellular carcinoma

Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy

Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma

Immunotherapy of hepatocellular carcinoma

Hyperthermia inhibits recombination repair of gemcitabine-stalled replication forks

Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study

Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy